Complement proteins in cerebrospinal fluid (CSF) and blood are differentially regulated in Alzheimer’s disease (AD) [23–28] and other neurodegenerative diseases compared to controls [29–32], but they have not been thoroughly investigated in FTD. Here, VTN is linked to neurodegenerative disease.